BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27869162)

  • 1. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.
    Wilson C; Qiu L; Hong Y; Karnik T; Tadros G; Mau B; Ma T; Mu Y; New J; Louie RJ; Gunewardena S; Godwin AK; Tawfik OW; Chien J; Roby KF; Krieg AJ
    Oncogene; 2017 May; 36(18):2565-2576. PubMed ID: 27869162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
    Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
    BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDM4B promotes epithelial-mesenchymal transition through up-regulation of ZEB1 in pancreatic cancer.
    Li S; Wu L; Wang Q; Li Y; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):997-1004. PubMed ID: 26511091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
    Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
    Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of β-catenin and colon cancer cell growth by the KDM4B histone demethylase.
    Berry WL; Kim TD; Janknecht R
    Int J Oncol; 2014 Apr; 44(4):1341-8. PubMed ID: 24481461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1.
    Xiang Y; Yan K; Zheng Q; Ke H; Cheng J; Xiong W; Shi X; Wei L; Zhao M; Yang F; Wang P; Lu X; Fu L; Lu X; Li F
    Cancer Res; 2019 Jan; 79(1):86-98. PubMed ID: 30459150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection.
    Yamada D; Kobayashi S; Yamamoto H; Tomimaru Y; Noda T; Uemura M; Wada H; Marubashi S; Eguchi H; Tanemura M; Doki Y; Mori M; Nagano H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S355-64. PubMed ID: 21607773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
    Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
    Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
    Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
    Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone demethylase KDM4B interacts with MyoD to regulate myogenic differentiation in C2C12 myoblast cells.
    Choi JH; Song YJ; Lee H
    Biochem Biophys Res Commun; 2015 Jan; 456(4):872-8. PubMed ID: 25534856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.
    Hua KT; Wang MY; Chen MW; Wei LH; Chen CK; Ko CH; Jeng YM; Sung PL; Jan YH; Hsiao M; Kuo ML; Yen ML
    Mol Cancer; 2014 Aug; 13():189. PubMed ID: 25115793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin.
    Ko SY; Naora H
    Mol Cancer; 2014 Jul; 13():170. PubMed ID: 25023983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase.
    Ipenberg I; Guttmann-Raviv N; Khoury HP; Kupershmit I; Ayoub N
    J Biol Chem; 2013 May; 288(21):14681-7. PubMed ID: 23589305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of histone demethylase KDM4B in Myc signaling in neuroblastoma.
    Yang J; AlTahan AM; Hu D; Wang Y; Cheng PH; Morton CL; Qu C; Nathwani AC; Shohet JM; Fotsis T; Koster J; Versteeg R; Okada H; Harris AL; Davidoff AM
    J Natl Cancer Inst; 2015 Jun; 107(6):djv080. PubMed ID: 25925418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
    Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
    Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
    Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progression.
    Tang H; Guan Y; Yuan Z; Guo T; Tan X; Fan Y; Zhang E; Wang X
    Epigenetics; 2023 Dec; 18(1):2192319. PubMed ID: 36952476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
    Ohyagi-Hara C; Sawada K; Kamiura S; Tomita Y; Isobe A; Hashimoto K; Kinose Y; Mabuchi S; Hisamatsu T; Takahashi T; Kumasawa K; Nagata S; Morishige K; Lengyel E; Kurachi H; Kimura T
    Am J Pathol; 2013 May; 182(5):1876-89. PubMed ID: 23499550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.